A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers
- First Posted Date
- 2010-12-31
- Last Posted Date
- 2013-09-04
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT01268839
A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients
Phase 2
Completed
- Conditions
- Human Immunodeficiency Virus (HIV)
- Interventions
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 54
- Registration Number
- NCT01199939
Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment
Phase 4
Completed
- Conditions
- HIV
- Interventions
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 68
- Registration Number
- NCT00757783
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
- First Posted Date
- 2007-09-24
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 23
- Registration Number
- NCT00534352
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT00460746
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
- First Posted Date
- 2006-09-27
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- Tibotec, Inc
- Target Recruit Count
- 429
- Registration Number
- NCT00381303
© Copyright 2025. All Rights Reserved by MedPath